LATEST NEWS IN PROSTATE CANCER

PCRI PCRI

On Stress: Thoughts from Mark & Mia Moyad

Yes, the PCRI Conference is a community or a village of people coming together to share the latest thoughts and ideas on how to deal with prostate cancer. And this, my friends, provides the ultimate calming effect; not only meeting others like you but also empowering each other with more knowledge and friendships and ultimately more solutions and peace of mind.

Read More
PCRI PCRI

Helpline Corner: Silvia Cooper, My Story

Silvia answers Helpline calls, lending a unique and valuable perspective to callers. This article shares some of her experiences with managing both her father’s and mother’s battle with cancer.

Read More
PCRI PCRI

Active Surveillance: Q&A with Dr. Laurence Klotz

Sunnybrook Health Sciences Centre’s Laurence Klotz, MD, speaks with PCRI about management of low-risk prostate cancer with Active Surveillance. 

What is active surveillance, and how does it compare with other methods of treating prostate cancer?

The concept of conservative management for prostate cancer is not new. In fact, in Scandinavia and England in the 70s, basically no one was treated until they had metastatic disease. And the idea was that treatment....

Read More
PCRI PCRI

Check Out The Prostate Cancer 101 Video Series

We're pleased to announce that we'll be working with KMI on videos for the new SHADES program. Stay tuned for more information on this groundbreaking patient education series.

In the mean, time check out our Prostate Cancer 101 video series below: 

Read More
PCRI PCRI

Seed Implant Radiation Therapy

LDR (low dose rate) brachytherapy for prostate cancer is more commonly known as seed implants. You may be familiar with this treatment option but for those of you who may be new to the confusing world of prostate cancer treatment, seed implants involve the insertion of small radioactive pellets or seeds into the prostate by transrectal ultrasound guidance, in order to deliver a focused dose of radiation to the prostate.

Read More